Sign In
Buy CSBR
$5.69
-0.0350 (-0.611%)
At Close: Jun 03, 2026
Champions Oncology Inc (NASDAQ:CSBR) is debt free
04:29pm, Tuesday, 14'th Dec 2021 FXDailyReport
Champions Oncology Inc (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative pharmacology, biomarker, and data platforms, stock rose 3.23% (As The post Champions Oncology Inc (NASDAQ:CSBR) is debt free appeared first on FXDailyReport.Com .
Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript
12:44am, Tuesday, 14'th Dec 2021 AlphaStreet
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris — President & Chief Executive Officer David Miller — Chief Financial Officer Analysts: Matt Hewitt — Craig-Hallum — Analyst […] The post Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript first appeared on AlphaStreet .
Champions Oncology Inc.''s (CSBR) CEO Ronnie Morris on Q2 2022 Results - Earnings Call Transcript
12:33am, Tuesday, 14'th Dec 2021 Seeking Alpha
Champions Oncology EPS beats by $0.02, beats on revenue
09:36pm, Monday, 13'th Dec 2021 Seeking Alpha
Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
09:32pm, Monday, 13'th Dec 2021 FinanzNachrichten
Reported income from operations of $263,000HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming…
Champions Oncology Inc.'s (CSBR) CEO Ronnie Morris on Q2 2022 Results - Earnings Call Transcript
07:33pm, Monday, 13'th Dec 2021
Champions Oncology Inc.'s (CSBR) CEO Ronnie Morris on Q2 2022 Results - Earnings Call Transcript
Champions Oncology, Inc.: Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
02:32pm, Monday, 06'th Dec 2021 FinanzNachrichten
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will repo
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
02:20pm, Monday, 06'th Dec 2021 Wallstreet:Online
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report its financial and operational results for the
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
09:20am, Monday, 06'th Dec 2021
HACKENSACK, NJ / ACCESSWIRE / December 6, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), leaders in transformative technology solutions utilized in oncology drug discovery and development will report
Patient Derived Xenograft Market Size to grow by USD 188.19 mn | Major Vendors Include Champions Oncology Inc. and Charles River Laboratories International Inc. | Technavio
04:00pm, Monday, 29'th Nov 2021 PR Newswire
NEW YORK, Nov. 29, 2021 /PRNewswire/ -- The patient derived xenograft market size is anticipated to grow by USD 188.19 mn, progressing at a CAGR of 16.66% during the forecast period. This exclusive market forecast report by Technavio covers market scenarios, estimates, and customer
Champions Oncology's (CSBR) CEO Ronnie Morris on Q1 FY2022 Results - Earnings Call Transcript
12:51pm, Tuesday, 14'th Sep 2021
Champions Oncology's (CSBR) CEO Ronnie Morris on Q1 FY2022 Results - Earnings Call Transcript
Champions Oncology, Inc. (CSBR) Reports Q1 Loss, Tops Revenue Estimates
06:49pm, Monday, 13'th Sep 2021
Champions Oncology, Inc. (CSBR) delivered earnings and revenue surprises of -200.00% and 2.30%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stoc
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
04:00pm, Monday, 13'th Sep 2021
HACKENSACK, NJ / ACCESSWIRE / September 13, 2021 / Champions Oncology, Inc. (Nasdaq:CSBR), leaders in transformative technology solutions utilized in drug discovery and development, today announced it
Champions Oncology, Inc. (CSBR) Reports Next Week: What You Should Expect
04:04pm, Monday, 06'th Sep 2021
Champions Oncology, Inc. (CSBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
04:30pm, Thursday, 02'nd Sep 2021
HACKENSACK, NJ / ACCESSWIRE / September 2, 2021 / Champions Oncology, Inc. (CSBR), leaders in transformative technology solutionsutilized in oncology drug discovery and development will report its fin
